Lockwood acquires medical animation studio ‘Random42’ from Graphite Capital
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
The partnership between Lockwood and Random42 expands the capabilities and geographic footprint for both organizations.
Follows Zealand Pharma’s appointment of Adam Steensberg as CEO and decision to refocus strategy
Facility features LED lighting, solar panels, automation and innovative temperature-controlled systems to maximize efficiency and minimize environmental impact
GSK to pay $2.1 billion upfront and up to $1.2 billion in potential development milestones
Construction will begin in early 2023, and the plant is scheduled to go onstream in 2025
Besides enhancing workflow operations by connecting scientists with their lab instruments and data, digitalization holds the potential to acceleratee long-term business growth
As per partnership, Carbanio will arrange raw materials and other custom chemicals for Proexp Pharma Pvt. Ltd. through an uninterrupted digital process of the company
PAYBACK loyalty will be live in 4500 Apollo Pharmacy outlets across India
The product will be launched by NATCO's commercial partner Viatris.
Subscribe To Our Newsletter & Stay Updated